Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Paragon spins out ninth biotech, sending cardiopulmonary drugs to Alaunos

Paragon Labs has created a ninth company, using a reverse merger model that it’s honed over the past four years to send Velaris Therapeutics straight onto the public markets. Velaris completed a transaction on Tuesday ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 13 October →